Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain.
Servicio de Traumatología y Cirugía Ortopédica, Hospital Universitario de Salamanca, Salamanca, Spain.
J Mater Sci Mater Med. 2017 Aug;28(8):115. doi: 10.1007/s10856-017-5928-1. Epub 2017 Jun 24.
Over the last decades, novel therapeutic tools for osteochondral regeneration have arisen from the combination of mesenchymal stromal cells (MSCs) and highly specialized smart biomaterials, such as hydrogel-forming elastin-like recombinamers (ELRs), which could serve as cell-carriers. Herein, we evaluate the delivery of xenogeneic human MSCs (hMSCs) within an injectable ELR-based hydrogel carrier for osteochondral regeneration in rabbits. First, a critical-size osteochondral defect was created in the femora of the animals and subsequently filled with the ELR-based hydrogel alone or with embedded hMSCs. Regeneration outcomes were evaluated after three months by gross assessment, magnetic resonance imaging and computed tomography, showing complete filling of the defect and the de novo formation of hyaline-like cartilage and subchondral bone in the hMSC-treated knees. Furthermore, histological sectioning and staining of every sample confirmed regeneration of the full cartilage thickness and early subchondral bone repair, which was more similar to the native cartilage in the case of the cell-loaded ELR-based hydrogel. Overall histological differences between the two groups were assessed semi-quantitatively using the Wakitani scale and found to be statistically significant (p < 0.05). Immunofluorescence against a human mitochondrial antibody three months post-implantation showed that the hMSCs were integrated into the de novo formed tissue, thus suggesting their ability to overcome the interspecies barrier. Hence, we conclude that the use of xenogeneic MSCs embedded in an ELR-based hydrogel leads to the successful regeneration of hyaline cartilage in osteochondral lesions.
在过去的几十年中,新型的骨软骨再生治疗工具已经从间充质基质细胞(MSCs)与高度专业化的智能生物材料(如形成水凝胶的弹性蛋白样重组体(ELRs))的结合中产生,这些材料可以作为细胞载体。在这里,我们评估了异种人骨髓间充质干细胞(hMSCs)在可注射 ELR 水凝胶载体中用于兔骨软骨再生的递呈情况。首先,在动物的股骨中创建了一个临界尺寸的骨软骨缺损,然后单独用 ELR 水凝胶或嵌入 hMSCs 填充该缺损。在三个月后,通过大体评估、磁共振成像和计算机断层扫描评估再生结果,显示 hMSC 处理的膝关节中完全填充了缺损,并新形成了透明软骨样软骨和软骨下骨。此外,对每个样本的组织切片和染色证实了完整软骨厚度的再生和早期软骨下骨修复,在细胞负载的 ELR 水凝胶的情况下,这与天然软骨更为相似。使用 Wakitani 量表对两组之间的总体组织学差异进行半定量评估,发现具有统计学意义(p < 0.05)。植入后三个月针对人线粒体抗体的免疫荧光染色显示,hMSCs 整合到新形成的组织中,因此表明它们能够克服种间屏障。因此,我们得出结论,异种 MSCs 嵌入 ELR 水凝胶中可成功再生骨软骨病变中的透明软骨。